BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Sunday, May 12, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 10, 2016
View Archived Issues
FDA clears IND for phase I/II trial of TWB-103 in split-thickness skin graft donor site wounds
Read More
TMEPAI shows promise as a therapeutic target in breast cancer
Read More
Researchers investigate potential epigenetic mechanism contributing to ADHD
Read More
LRBA is novel molecular target with applications in transplant immunology
Read More
Fortress Biotech forms subsidiary to develop TBI treatments
Read More
Serum miRNAs as novel noninvasive biomarkers for the diagnosis of osteoporosis
Read More
MTHFR c.677T is a protective factor of prostate cancer risk in Chinese males
Read More
Mabion signs development and commercialization agreement with Mylan for Mabion-CD20
Read More
Evotec enters into novel strategic partnership with University of Oxford
Read More
European Commission approves Ibrance for HR-positive, HER2-negative metastatic breast cancer
Read More
Cell Medica and Baylor to develop off-the-shelf allogeneic cell therapy for cancer
Read More
Sosei subsidiaries collaborate to develop novel peptide candidates targeting GPCR for GI disorders
Read More
Aganirsen given FDA orphan designation for preventing corneal graft rejection
Read More
Sumitomo Dainippon Pharma patents dopamine D4 receptor agonists
Read More
CymaBay Therapeutics' MBX-8025 receives FDA orphan drug designation
Read More
ViiV Healthcare UK discloses antiviral agents
Read More
Takeda Pharmaceutical describes orexin receptor antagonists
Read More
Kainos Medicine develops Brd inhibitors
Read More
Lead Discovery Center and Qurient present TAM receptor kinases and/or MET inhibitors
Read More
Ono Pharmaceutical updates progress of second quarter of fiscal 2016
Read More
Matinas' LCNP influenza vaccine protects from infection in preclinical trial
Read More
Imugene initiates phase Ib/II study of HER-Vaxx in gastric cancer
Read More
FDA grants fast track designation to NS-065 for Duchenne muscular dystrophy
Read More
Bristol-Myers Squibb and Infinity Pharmaceuticals sign collaboration
Read More